NCT02224573View on ClinicalTrials.gov

An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes

PHASE3CompletedINTERVENTIONAL

Enrollment

681

Participants

Timeline

Start Date

June 11, 2015

Primary Completion Date

September 24, 2020

Study Completion Date

September 24, 2020

Conditions

EpilepsyDravet SyndromeLennox-Gastaut Syndrome

Interventions

DRUG

GWP42003-P

Sponsors

Lead Sponsor

GW Research Ltd

All Listed Sponsors

lead

GW Research Ltd

INDUSTRY